Pharma Market Access Insights - from Mtech Access

64 Episodes

1. Market access in the German speaking markets

   Published: 8/29/2023
2. The role of nursing in driving digital change in the NHS

   Published: 7/26/2023
3. Market access for digital therapies and digital medicines

   Published: 7/19/2023
4. A global market access journey in cannabinoid pharmaceuticals

   Published: 6/17/2023
5. Primary Care and ICBs – what is the next step in the integration journey?

   Published: 5/15/2023
6. Data-led transformation in the NHS - partnering to optimise patient care

   Published: 3/31/2023
7. Innovating for better health – research, collaboration and innovation in the NHS

   Published: 3/7/2023
8. Healthcare, economics and society – unlocking NHS collaboration

   Published: 1/30/2023
9. Specialised Commissioning in the NHS – What do you need to know now

   Published: 1/13/2023
10. Why are we waiting? - Pressures facing the NHS and how to deliver change

    Published: 11/29/2022
11. Priority setting in primary care - NHS insights

    Published: 10/18/2022
12. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    Published: 8/9/2022
13. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    Published: 8/1/2022
14. Transforming systems and care pathways for an integrated NHS

    Published: 6/21/2022
15. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    Published: 5/4/2022
16. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    Published: 3/15/2022
17. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    Published: 2/11/2022
18. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    Published: 1/17/2022
19. Optimising the NHS – How will medicines be valued in integrated systems?

    Published: 12/21/2021
20. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    Published: 11/29/2021